Role of nutraceuticals on neurodegenerative diseases: neuroprotective and immunomodulant activity

Nat Prod Res. 2022 Nov;36(22):5916-5933. doi: 10.1080/14786419.2021.2020265. Epub 2021 Dec 29.

Abstract

Neurodegeneration is a degenerative process characterized by the progressive loss of the structure and function of neurons that involves several immune cells. It is the primary cause of dementia and other several syndromes, known as neurodegenerative diseases. These disorders are age-related and it is estimated that by 2040 there will be approximately 81.1 million people suffering from these diseases. In addition to the traditional pharmacological therapy, in recent years nutraceuticals, naturally based compounds with a broad spectrum of biological effects: anti-aging, antioxidants, hypoglycaemic, hypocholesterolemic, anticancer, anxiolytic, antidepressant, etc., assumed an important role in counteracting these pathologies. In particular, several compounds such as astaxanthin, baicalein, glycyrrhizin, St. John's wort, and Ginkgo biloba L. extracts show particular neuroprotective and immunomodulatory abilities, involving several immune cells and some neurotransmitters that play a critical role in neurodegeneration, making them particularly useful in improving the symptoms and progression of neurodegenerative diseases.

Keywords: Neurodegenerative diseases; immune system; neuroinflammation; neuroprotection; nutraceuticals.

MeSH terms

  • Antidepressive Agents / pharmacology
  • Dietary Supplements
  • Humans
  • Hypericum* / chemistry
  • Neurodegenerative Diseases* / drug therapy
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Plant Extracts
  • Antidepressive Agents